Akso Health Group ADR (AHG)vsMcKesson Corporation (MCK)
AHG
Akso Health Group ADR
$1.34
-8.22%
HEALTHCARE · Cap: $1.15B
MCK
McKesson Corporation
$775.66
+2.47%
HEALTHCARE · Cap: $91.29B
Smart Verdict
WallStSmart Research — data-driven comparison
McKesson Corporation generates 2718010% more annual revenue ($403.43B vs $14.84M). MCK leads profitability with a 1.2% profit margin vs 0.0%. MCK earns a higher WallStSmart Score of 53/100 (C-).
AHG
Avoid16
out of 100
Grade: F
MCK
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+18.0%
Fair Value
$1.72
Current Price
$1.34
$0.38 discount
Margin of Safety
-65.2%
Fair Value
$576.90
Current Price
$775.66
$198.76 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Earnings expanding 37.2% YoY
Generating 3.3B in free cash flow
Areas to Watch
0.9% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Expensive relative to growth rate
ROE of 0.0% — below average capital efficiency
1.2% margin — thin
Operating margin of 2.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.
Bull Case : MCK
The strongest argument for MCK centers on Debt/Equity, Altman Z-Score, Market Cap.
Bear Case : AHG
The primary concerns for AHG are Revenue Growth, EPS Growth, Market Cap.
Bear Case : MCK
The primary concerns for MCK are PEG Ratio, Return on Equity, Profit Margin. Thin 1.2% margins leave little buffer for downturns.
Key Dynamics to Monitor
MCK carries more volatility with a beta of 0.32 — expect wider price swings.
MCK is growing revenue faster at 6.0% — sustainability is the question.
MCK generates stronger free cash flow (3.3B), providing more financial flexibility.
Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MCK scores higher overall (53/100 vs 16/100). AHG offers better value entry with a 18.0% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading innovator in the healthcare sector, focused on delivering advanced medical solutions and comprehensive patient care services. The company harnesses state-of-the-art health technologies to drive growth in areas such as telehealth and personalized medicine, supported by a strong emphasis on research and development. With a resilient business model and a dedicated team, Akso Health Group presents an attractive investment opportunity for institutional investors, poised to capitalize on the ongoing transformation within the healthcare industry.
Visit Website →McKesson Corporation
HEALTHCARE · MEDICAL DISTRIBUTION · USA
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?